Findings

What do systematic reviews say?

4 questions · 6 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 6 · 100%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Patients who progressed ‐ at 2 years · people with multiple sclerosis

Glatiramer acetate showed no clear difference in patients who progressed ‐ at 2 years compared with placebo; GRADE not reported.

2 findings from 1 review

Glatiramer acetate for multiple sclerosis 2010 · Cochrane Headline outcomes only
RR 0.75 [0.51, 1.12]
2 studies · 299 participants
GRADE not reported
Glatiramer acetate for multiple sclerosis 2010 · Cochrane Headline outcomes only
RR 0.81 [0.5, 1.29]
1 study · 203 participants
GRADE not reported

Change in disability score at the end of · people with multiple sclerosis

2 findings from 1 review

Glatiramer acetate for multiple sclerosis 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 301 participants
GRADE not reported
Glatiramer acetate for multiple sclerosis 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 203 participants
GRADE not reported

Relapse · people with multiple sclerosis

1 finding from 1 review

Glatiramer acetate for multiple sclerosis 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 287 participants
GRADE not reported

Mean number of relapses ‐ at 2 years of · people with multiple sclerosis

1 finding from 1 review

Glatiramer acetate for multiple sclerosis 2010 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 298 participants
GRADE not reported